Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 407.25
+11.75 (2.97%)
Aug 21, 2026, 3:30 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 162.13 billion as of August 21, 2026. Its market cap has decreased by -38.98% in one year.
Market Cap
162.13B
Enterprise Value
153.82B
Revenue
36.00B
Ranking
n/a
PE Ratio
74.49
Stock Price
407.25
ChartMarket Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 162.13B, an increase of 161.03%. That is a compound annual growth rate of 9.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 162.13B | -37.44% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.56T |
| Divi's Laboratories | 2.28T |
| Apollo Hospitals Enterprise | 1.25T |
| Cipla | 1.16T |
| OneSource Specialty Pharma | 175.98B |
| Alivus Life Sciences | 165.81B |
| Concord Biotech | 164.38B |
| Alembic Pharmaceuticals | 161.53B |